ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,917.11
0.00%
Dow Jones
43,408.47
0.32%
US Dollar vs MXN
20.3433
0.30%
Brent Oil
73.51
0.92%
Bitcoin
97,689.43
3.53%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Genfit (GNFT) Cotización

Genfit

Genfit (GNFT)

Genfit SA
4.015
-0.01
( -0.25% )
Actualizado: 03:45:23
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
4.015
Postura de Compra
4.01
Postura de Venta
4.03
Volume Operado de la Acción
64,862
4.00 Rango del Día 4.08
2.90 Rango de 52 semanas 5.86
Capitalización de Mercado [m]
200.087M
Precio Anterior
4.025
Precio de Apertura
4.025
Hora
597
@
4.015
Última hora de negociación
03:42:23
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
329,918
Acciones en circulación
49,834,983
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-6.99
Beneficio por acción (BPA)
-0.58
turnover
38.68M
Beneficio neto
-28.89M

Acerca de Genfit

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.genfit.com
Sede
Loos, Nord, Fra
Fundado
-
Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 4.03 €. Over the last year, Genfit shares have traded in a share price range of 2.90 € to 5.86 €.

Genfit currently has 49,834,983 shares in issue. The market capitalisation of Genfit is 200.59 € million. Genfit has a price to earnings ratio (PE ratio) of -6.99.

GNFT Últimas noticias

Más noticias

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

13 Noviembre 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

13 Noviembre 2024
UK Regulatory

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

13 Noviembre 2024
GlobeNewswire Inc.

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

07 Noviembre 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

07 Noviembre 2024
UK Regulatory

GENFIT Reports Third Quarter 2024 Financial Information

Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

07 Noviembre 2024
GlobeNewswire Inc.

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

23 Septiembre 2024
UK Regulatory

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

23 Septiembre 2024
UK Regulatory

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

23 Septiembre 2024
GlobeNewswire Inc.

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

19 Septiembre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.875-17.89366053174.894.95543890694.21865211DE
4-1.115-21.73489278755.135.6343089324.84695135DE
120.2055.380577427823.815.863.6253299184.88489033DE
260.1955.104712041883.825.863.473368284.60069643DE
520.86527.46031746033.155.862.92661904.1943634DE
1560.83726.33731906863.1785.862.7462144903.94029017DE
260-9.885-71.115107913713.920.962.7463087035.60555573DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALMASMastrad
0.0136 €
(58.14%)
976.27k
BIDSGascogne DS
0.0028 €
(55.56%)
40.05k
SOISOITEC
75.20 €
(18.43%)
193.43k
HYLHyloris Pharmaceuticals SA
5.88 €
(13.51%)
36.48k
ATODSAtos SE
0.0046 €
(12.20%)
12.01M
EBUSEbusco Holding NV
0.918 €
(-25.12%)
1.47M
VACBSPierre & Vacances
0.048 €
(-14.29%)
427
EMGDSEuromedis DS
0.0088 €
(-12.00%)
2.65k
ALVETTheraVet SA
0.0804 €
(-10.67%)
28.93k
ALAIRGroupe Airwell
1.43 €
(-9.49%)
1.57k
ATODSAtos SE
0.0046 €
(12.20%)
12.01M
ALVERVergnet
0.005 €
(4.17%)
7.64M
ALTDTonner Drones
0.0102 €
(10.87%)
6.92M
BCPBanco Comercial Portugues SA
0.4354 €
(-1.00%)
6.87M
ATOAtos SE
0.1767 €
(-8.21%)
2.8M

Discusión

Ver feed completo
aniyahsbednar aniyahsbednar 4 minutos hace
https://claritybloomcbdgummies.linkpc.net/
aniyahsbednar aniyahsbednar 5 minutos hace
https://www.facebook.com/vitaslimketogummies/
Patient Ninja Patient Ninja 5 minutos hace
Tommy got close to half million in bitcoin as it gets close to 100k. He may have more bitcoin now. Maybe a million worth.

Sell some bitcoin Tommy. Pay off the corrupt MM and let's get going buddy.

After that we can show a paid poster and basher where the sun don't shi
CCTL
Golden Cross Golden Cross 6 minutos hace
$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR
XenaLives XenaLives 7 minutos hace
LOL!!! DFCO is a typical BONAR pump and dump.

No fundamentals at all here.....
DFCO
Methinks Methinks 7 minutos hace
https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/
Found this, and thanks, Bull_Dolphin. I look forward to hearing more about the DAAS partnership.
WYY
aniyahsbednar aniyahsbednar 7 minutos hace
Official Website... https://cutt.ly/BeKWwPJc

Vital Grow XL Gummies are formulated to enhance male performance, vitality, and overall wellness. Designed with convenience and natural ingredients in mind, these gummies aim to provide benefits like improved stamina, testosterone support,
Golden Cross Golden Cross 8 minutos hace
$ILLR ✨ ILLR Update: Former Head of Product at TikTok Sean Kim joins Triller Group
https://www.youtube.com/watch?v=2Nq9YJiZt8U

[yt]2Nq9YJiZt8U[/yt]
ILLR
Methinks Methinks 11 minutos hace
https://www.widepoint.com/widepoint-certifies-new-proprietary-mobileanchor-digital-credential-for-mobile-devices/

"Direct Integration: WidePoint’s MobileAnchor™ generates a digital credential directly on the device, can leverage device-specific security features, such as hardware-base
diggitydoodle diggitydoodle 16 minutos hace
A lot of giving opinions, predicting, hoping & wishing what this tickers great CEO will do. Based on reading into things without those things specifically being written in any of the reports coming out.
This great CEO can't put out timely fins. And, doesn't give updates, even of the most gen
RNVA
TheFinalCD TheFinalCD 16 minutos hace
RMSG 7
CRAZY SWINGS FROM
55- TO 2.65 TO 10.70

RMSG
https://finance.yahoo.com/news/real-messenger-nova-vision-acquisition-210800321.html
RMSG
aniyahsbednar aniyahsbednar 18 minutos hace
Official Website... https://cutt.ly/keKQ376J

MaxBoost Plus is a premium male enhancement supplement designed to help men improve stamina, vitality, and overall confidence. Using a powerful blend of natural ingredients, it supports testosterone levels, blood flow, and energy, empowerin
TrendTrade2016 TrendTrade2016 18 minutos hace
BDPT FIRST TRIP REVERSE SPLIT TO HIT...GET READY CLOWNS...THIS IS THE BEGINNING TO THEBIGGEST OTC RS CAMPAIGN IN A DECADE
BDPTD
Truth_is_a_tool Truth_is_a_tool 22 minutos hace
I feel a disturbance in the force too lol and I’m going to go ahead and agree. I feel we will have a PR in less than 3 hours.
KBLB
Truth_is_a_tool Truth_is_a_tool 24 minutos hace
Hi M4N , my concern was that it was in the latest prospectus that just came out but you and Mojo are probably right that it’s just a copy and paste. Either way im not really concerned as it doesn’t change my view that this company will have a breakout soon enough , whether it’s this year or the next
KBLB
Bull_Dolphin Bull_Dolphin 26 minutos hace
Yay!!!!

https://www.breitbart.com/entertainment/2024/11/20/ellen-degeneres-leaves-united-states-flees-to-england-over-trump-election/
Minddoc7 Minddoc7 26 minutos hace
Coinbase CEO Brian Armstrong Perfect For Crypto Czar Role - Charles Hoskinson

"Cardano founder Charles Hoskinson has thrown his weight behind Coinbase CEO Brian Armstrong as the best choice for a potential “crypto czar” position in the Trump administration.

The informal
COIN
Seminole Red Seminole Red 28 minutos hace
good job
cowtown jay cowtown jay 30 minutos hace
How much longer can it be before we start to see detailed stock quotes on this site (advfn) again? So many pieces of the puzzle are starting to be displayed, they have got to be near the point where they are snapped together. We've got to be generating revenue by now.

https://www.ad
aniyahsbednar aniyahsbednar 32 minutos hace
Official Website... https://cutt.ly/qeKQMuOM

VitalRize Male Enhancement is a cutting-edge supplement designed to help men regain their stamina, boost testosterone levels, and improve overall confidence. With a blend of natural and clinically tested ingredients, VitalRize offers a holi

Su Consulta Reciente

EU
GNFT
Genfit
ASX
PFE
Pantera Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados